Richter Gedeon Vegyeszeti Gyar Nyilvanosan Muko Rt 2024 AR2
The report highlights Gedeon Richter Plc.'s record-high financial results for 2024, with pharmaceutical revenues growing by 13% to HUF 845 billion and net income increasing by 51% to HUF 239 billion. The company expanded its Women's Healthcare portfolio through the strategic acquisitions of Belgian subsidiaries Estetra SRL and Neuralis SA, as well as BCI Pharma. Additionally, Richter became a 100% owner of joint ventures Richter-Helm Biologics and Richter-Helm BioTec. In sustainability, the company reduced its environmental footprint, with group-level Scope 1-2-3 greenhouse gas emissions falling by 4%, and initiated alignment of its carbon targets with the Science Based Targets initiative (SBTi).
Company: Richter Gedeon Vegyeszeti Gyar Nyilvanosan Muko Rt
Sector: Health Care
Country: Hungary
Year: 2024
Type: AR2
Pages: 500
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Muko Rt
Annual Report
The report highlights Gedeon Richter Plc.'s record-high financial results for 2024, with pharmaceutical revenues growing by 13% to HUF 845 billion and net income increasing by 51% to HUF 239 billion. The company expanded its Women's Healthcare portfolio through the strategic acquisitions of Belgian subsidiaries Estetra SRL and Neuralis SA, as well as BCI Pharma. Additionally, Richter became a 100% owner of joint ventures Richter-Helm Biologics and Richter-Helm BioTec. In sustainability, the company reduced its environmental footprint, with group-level Scope 1-2-3 greenhouse gas emissions falling by 4%, and initiated alignment of its carbon targets with the Science Based Targets initiative (SBTi).
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees